Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - TANDEM DIABETES CARE INCtndm-20191231xex322.htm
EX-32.1 - EXHIBIT 32.1 - TANDEM DIABETES CARE INCtndm-20191231xex321.htm
EX-31.2 - EXHIBIT 31.2 - TANDEM DIABETES CARE INCtndm-20191231xex312.htm
EX-31.1 - EXHIBIT 31.1 - TANDEM DIABETES CARE INCtndm-20191231xex311.htm
EX-10.36 - EXHIBIT 10.36 LEASE AGREEMENT - TANDEM DIABETES CARE INCtndm-20191231xex1036.htm
EX-4.1 - EXHIBIT 4.1 DESCRIPTION OF CAPITAL STOCK - TANDEM DIABETES CARE INCtndm-20191231xex47.htm
10-K - 10-K - TANDEM DIABETES CARE INCtndm-20191231x10k.htm
Exhibit 23.1



 
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration Statement (Form S-3 No. 333-222143) of Tandem Diabetes Care, Inc.,
(2) Registration Statement (Form S-8 No. 333-226944) pertaining to the 2013 Stock Incentive Plan of Tandem Diabetes Care Inc.,
(3) Registration Statement (Form S-8 No. 333-226915) pertaining to the 2013 Stock Incentive Plan, and 2013 Employee Stock Purchase Plan of Tandem Diabetes Care Inc.,
(4) Registration Statement (Form S-8 No. 333-192406) pertaining to the 2006 Stock Incentive Plan, 2013 Stock Incentive Plan, and 2013 Employee Stock Purchase Plan of Tandem Diabetes Care Inc.,
(5) Registration Statement (Form S-8 No. 333-202254) pertaining to the 2013 Stock Incentive Plan and 2013 Employee Stock Purchase Plan of Tandem Diabetes Care, Inc.,
(6) Registration Statement (Form S-8 No. 333-209685) pertaining to the 2013 Stock Incentive Plan and 2013 Employee Stock Purchase Plan of Tandem Diabetes Care, Inc.,
(7) Registration Statement (Form S-8 No. 333-223377) pertaining to the 2013 Stock Incentive Plan and 2013 Employee Stock Purchase Plan of Tandem Diabetes Care Inc., and
(8) Registration Statement (Form S-8 No. 333-216529) pertaining to the 2013 Stock Incentive Plan and 2013 Employee Stock Purchase Plan of Tandem Diabetes Care Inc;
of our reports dated February 24, 2020, with respect to the consolidated financial statements of Tandem Diabetes Care, Inc. and the effectiveness of internal control over financial reporting of Tandem Diabetes Care, Inc., included in this Annual Report (Form 10-K) of Tandem Diabetes Care, Inc. for the year ended December 31, 2019.
/s/Ernst & Young LLP

San Diego, California
February 24, 2020